BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29296410)

  • 1. Overview of dosimetric and biological perspectives on radiosurgery of multiple brain metastases in comparison with whole brain radiotherapy.
    Xue J; LaCouture T; Grimm J; Goldman HW; Ibbott GS; Yorke E; Kubicek GJ
    J Radiosurg SBRT; 2015; 3(4):271-279. PubMed ID: 29296410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heuristic knowledge-based planning for single-isocenter stereotactic radiosurgery to multiple brain metastases.
    Ziemer BP; Sanghvi P; Hattangadi-Gluth J; Moore KL
    Med Phys; 2017 Oct; 44(10):5001-5009. PubMed ID: 28731267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal Sparing Whole Brain Radiotherapy and Integrated Simultaneous Boost vs Stereotactic Radiosurgery Boost: A Comparative Dosimetric Planning Study.
    Cheah SK; Matthews T; Teh BS
    Asian Pac J Cancer Prev; 2016; 17(9):4233-4235. PubMed ID: 27797223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric feasibility of brain stereotactic radiosurgery with a 0.35 T MRI-guided linac and comparison vs a C-arm-mounted linac.
    Slagowski JM; Redler G; Malin MJ; Cammin J; Lobb EC; Lee BH; Sethi A; Roeske JC; Flores-Martinez E; Stevens T; Yenice KM; Green O; Mutic S; Aydogan B
    Med Phys; 2020 Nov; 47(11):5455-5466. PubMed ID: 32996591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of dosimetry distribution for patients with multiple brain metastases from non-small cell lung cancer by a Cyberknife stereotactic radiosurgery (SRS) system.
    Yu X; Wang Y; Yuan Z; Yu H; Song Y; Zhao L; Wang P
    BMC Cancer; 2020 Nov; 20(1):1144. PubMed ID: 33238967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases.
    Manning MA; Cardinale RM; Benedict SH; Kavanagh BD; Zwicker RD; Amir C; Broaddus WC
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):603-8. PubMed ID: 10837942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatiotemporal fractionation schemes for stereotactic radiosurgery of multiple brain metastases.
    Torelli N; Papp D; Unkelbach J
    Med Phys; 2023 Aug; 50(8):5095-5114. PubMed ID: 37318898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique.
    Ruggieri R; Naccarato S; Mazzola R; Ricchetti F; Corradini S; Fiorentino A; Alongi F
    Radiat Oncol; 2018 Mar; 13(1):38. PubMed ID: 29506539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and TomoTherapy stereotactic radiosurgery.
    Zhang I; Antone J; Li J; Saha S; Riegel AC; Vijeh L; Lauritano J; Marrero M; Salas S; Schulder M; Zinkin H; Goenka A; Knisely J
    Pract Radiat Oncol; 2017; 7(3):183-189. PubMed ID: 28477798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases.
    Redmond KJ; Gui C; Benedict S; Milano MT; Grimm J; Vargo JA; Soltys SG; Yorke E; Jackson A; El Naqa I; Marks LB; Xue J; Heron DE; Kleinberg LR
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):53-67. PubMed ID: 33390244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal dose from stereotactic radiosurgery for 4 to 10 brain metastases: Risk factors, feasibility of dose reduction via re-optimization, and patient outcomes.
    Birer SR; Olson AC; Adamson J; Hood R; Susen M; Kim G; Salama JK; Kirkpatrick JP
    Med Dosim; 2017 Winter; 42(4):310-316. PubMed ID: 28760560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose homogeneity analysis of adjuvant radiation treatment in surgically resected brain metastases: Comparison of IORT, SRS, and IMRT indices.
    Dahshan BA; Weir JS; Bice RP; Renz P; Cifarelli DT; Poplawski L; Hack J; Vargo JA; Cifarelli CP
    Brachytherapy; 2021; 20(2):426-432. PubMed ID: 33454200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Fraction Stereotactic Radiosurgery Versus Hippocampal-Avoidance Whole Brain Radiation Therapy for Patients With 10 to 30 Brain Metastases: A Dosimetric Analysis.
    Nguyen TK; Sahgal A; Detsky J; Soliman H; Myrehaug S; Tseng CL; Husain ZA; Carty A; Das S; Yang V; Lee Y; Sarfehnia A; Chugh BP; Yeboah C; Ruschin M
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):394-399. PubMed ID: 31283978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of dose escalation using intraoperative radiotherapy following resection of large brain metastases compared to post-operative stereotactic radiosurgery.
    Vargo JA; Sparks KM; Singh R; Jacobson GM; Hack JD; Cifarelli CP
    J Neurooncol; 2018 Nov; 140(2):413-420. PubMed ID: 30094718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.